The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...
Eli Lilly & Co. (NYSE: LLY) shares are trading higher Thursday after the company launched its weight-loss drug Mounjaro in ...
Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...
GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...
Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...
The much-awaited launch of Mounjaro, an injectable drug used to treat obesity, overweight, and type 2 diabetes, has been ...
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...
Lilly Hiatt, the sensational Nashville singer-songwriter who has been creating exciting and eclectic music for years, is now ...
Two Floridian icons, Lilly Pulitzer and Disney, have just teamed up for their biggest collaboration yet, and it’s exactly ...
Weight loss injectables like Ozempic have gained popularity in Bengaluru, with patients sourcing them from abroad. The ...
We recently published a list of Jim Cramer Discusses These 10 Stocks & Says Trump Should Carry A Howitzer And Be Soft. In ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results